2014-2018 World Cyclospora Testing Market: Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-- US, Europe (France, Germany, Italy, Spain, UK), Japan

Date: November 7, 2014
Pages: 191
Price:
US$ 4,350.00 US$ 3,480.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C76EEBFA761EN
Leaflet:

Download PDF Leaflet

2014-2018 World Cyclospora Testing Market: Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-- US, Europe (France, Germany, Italy, Spain, UK), Japan
The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Cyclospora tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.Contains 191 pages and 7 tables
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
  • Asymptomatic Infection
  • Diarrhea in Immunocompetent Persons
  • Diarrhea in Immunocompromisedersons
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
  1. DNA Probes
    a. Technology Overview
    b. Amplification Methods
  • Polymerase Chain Reaction
    • Robotics
    • Temperature Cyclers
    • PCR Variations
  • Immuno-PCR
  • QC-PCR
  • DAP-PCR
  • Ligase Chain Reaction
  • Branched DNA
  • Q-Beta Replicase
  • Nucleic-Acid Sequence-Based
  • Strand Displacement Activation
  • Self-Sustained Sequence Replicase
  2. Monoclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
  • Overview
  • ELISA
  • Dot Immunobinding Assays
  • Capillary Immunoassays
  • Particle-Membrane Capture Immunoassays
  • Enzyme Amplification
    c. Fluorescent Immunoassays
  • Fluorescence Polarization
  • Time-Resolved Pulse Fluorescence
    d. Luminescence
  • Chemiluminescence
  • Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Differential Light Scattering
  5. Microcomputers and Automation
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. MRI
  11. Gel Microdroplets
  12. Other

III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS
  • Abbott
  • Affymetrix
  • Applera
  • Beckman Coulter
  • Becton Dickinson
  • Binding Site
  • Biomerica
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotrol
  • Biosite
  • Biotest
  • Caliper Technologies
  • Cepheid
  • Chemicon
  • Daiichi
  • DiaSorin
  • Diagast
  • Diamedix
  • Digene
  • Eiken
  • Enzo Biochem
  • Fujirebio
  • GenBio
  • Gene-Tec
  • Hemagen
  • Immunetics
  • Innogenetics
  • Inverness
  • J&J
  • Meridian
  • Nanogen
  • Nissui
  • Olympus
  • Provalis
  • Roche
  • Saliva Diagnostic
  • SeraCare
  • Siemens
  • Third Wave Technologies
  • Thermo Fisher
  • Tosho
  • Trinity Biotech
  • Tropix
  • Wampole Labs
  • Zenith
  • Zeus

LIST OF TABLES

France Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Skip to top


Ask Your Question

2014-2018 World Cyclospora Testing Market: Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-- US, Europe (France, Germany, Italy, Spain, UK), Japan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: